Source Name Comment [rna_tube] Comment [sample_name] Comment [organism] Comment [barcode] Protocol REF Parameter [rna_extraction] Extract Name Comment [rna_id] Comment [Material Type] Comment [comment_on_rna] Protocol REF Comment [lsid] Parameter [library_protocol] Library Name Comment [library_id] Protocol REF Parameter [sequence_protocol] Parameter [machine_name] Parameter [run_name] Parameter [flowcell.channel] File Name Comment [sequence_raw_file] Protocol REF Parameter [sex] File Name 10508-107D4 10508-107D4 neuroblastoma cell line:CHP-134, tech_rep1 Homo sapiens GCTATA standard whole cell standard whole cell 10508-107D4.rna 10508-107D4.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:7.8; A260A280:2.08; A260A230:2.08 OP-SOLEXA-nanoCAGE-Direct-v1.4 860 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10062 NCig10062 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep1.NCig10062.10508-107D4.hg19.GCTATA.bam 10552-107I3 10552-107I3 cervical cancer cell line:D98-AH2, tech_rep1 Homo sapiens GCTATA standard whole cell standard whole cell 10552-107I3.rna 10552-107I3.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.4; A260A280:2.1; A260A230:2.1 OP-SOLEXA-nanoCAGE-Direct-v1.4 860 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10063 NCig10063 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep1.NCig10063.10552-107I3.hg19.GCTATA.bam 10558-107I9 10558-107I9 osteosarcoma cell line:HS-Os-1, tech_rep1 Homo sapiens GCTATA standard whole cell standard whole cell 10558-107I9.rna 10558-107I9.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.4; A260A280:2.11; A260A230:2.17 OP-SOLEXA-nanoCAGE-Direct-v1.4 860 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10064 NCig10064 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep1.NCig10064.10558-107I9.hg19.GCTATA.bam 10410-106B5 10410-106B5 extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS, tech_rep1 Homo sapiens GCTATA standard whole cell standard whole cell 10410-106B5.rna 10410-106B5.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.2; A260A280:1.99; A260A230:1.96 OP-SOLEXA-nanoCAGE-Direct-v1.4 860 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10065 NCig10065 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep1.NCig10065.10410-106B5.hg19.GCTATA.bam 10441-106E9 10441-106E9 synovial sarcoma cell line:HS-SY-II, tech_rep1 Homo sapiens GCTATA standard whole cell standard whole cell 10441-106E9.rna 10441-106E9.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.5; A260A280:2.09; A260A230:0.76 OP-SOLEXA-nanoCAGE-Direct-v1.4 860 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10066 NCig10066 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep1.NCig10066.10441-106E9.hg19.GCTATA.bam 10474-106I6 10474-106I6 myeloma cell line:PCM6, tech-rep1 Homo sapiens GCTATA standard whole cell standard whole cell 10474-106I6.rna 10474-106I6.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:8.9; A260A280:2.1; A260A230:0.99 OP-SOLEXA-nanoCAGE-Direct-v1.4 860 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10067 NCig10067 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female myeloma%20cell%20line%3aPCM6%2c%20tech-rep1.NCig10067.10474-106I6.hg19.GCTATA.bam 10424-106D1 10424-106D1 splenic lymphoma with villous lymphocytes cell line:SLVL Homo sapiens GCTATA standard whole cell standard whole cell 10424-106D1.rna 10424-106D1.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:10; A260A280:1.92; A260A230:2.25 OP-SOLEXA-nanoCAGE-Direct-v1.4 860 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10068 NCig10068 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ /sequencedata/Solexa/110202_HWUSI-EAS566_00027_FC_62E96AAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female splenic%20lymphoma%20with%20villous%20lymphocytes%20cell%20line%3aSLVL.NCig10068.10424-106D1.hg19.GCTATA.bam 10411-106B6 10411-106B6 renal cell carcinoma cell line:OS-RC-2 Homo sapiens GCTATA standard whole cell standard whole cell 10411-106B6.rna 10411-106B6.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.2; A260A280:2.08; A260A230:1.26 OP-SOLEXA-nanoCAGE-Direct-v1.4 865 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10053 NCig10053 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110513_HWUSI-EAS747_00039_FC_64GPCAAXX/ /sequencedata/Solexa/110513_HWUSI-EAS747_00039_FC_64GPCAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male renal%20cell%20carcinoma%20cell%20line%3aOS-RC-2.NCig10053.10411-106B6.hg19.GCTATA.bam 10412-106B7 10412-106B7 malignant trichilemmal cyst cell line:DJM-1 Homo sapiens GCTATA standard whole cell standard whole cell 10412-106B7.rna 10412-106B7.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:8; A260A280:2; A260A230:1.88 OP-SOLEXA-nanoCAGE-Direct-v1.4 865 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10054 NCig10054 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110513_HWUSI-EAS747_00039_FC_64GPCAAXX/ /sequencedata/Solexa/110513_HWUSI-EAS747_00039_FC_64GPCAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female malignant%20trichilemmal%20cyst%20cell%20line%3aDJM-1.NCig10054.10412-106B7.hg19.GCTATA.bam 10414-106B9 10414-106B9 maxillary sinus tumor cell line:HSQ-89 Homo sapiens GCTATA standard whole cell standard whole cell 10414-106B9.rna 10414-106B9.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:8.2; A260A280:1.97; A260A230:1.99 OP-SOLEXA-nanoCAGE-Direct-v1.4 866 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10055 NCig10055 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male maxillary%20sinus%20tumor%20cell%20line%3aHSQ-89.NCig10055.10414-106B9.hg19.GCTATA.bam 10431-106D8 10431-106D8 epidermoid carcinoma cell line:Ca Ski Homo sapiens GCTATA standard whole cell standard whole cell 10431-106D8.rna 10431-106D8.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.9; A260A280:1.96; A260A230:1.75 OP-SOLEXA-nanoCAGE-Direct-v1.4 866 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10056 NCig10056 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female epidermoid%20carcinoma%20cell%20line%3aCa%20Ski.NCig10056.10431-106D8.hg19.GCTATA.bam 10436-106E4 10436-106E4 signet ring carcinoma cell line:Kato III Homo sapiens GCTATA standard whole cell standard whole cell 10436-106E4.rna 10436-106E4.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.2; A260A280:2; A260A230:1.35 OP-SOLEXA-nanoCAGE-Direct-v1.4 866 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10057 NCig10057 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male signet%20ring%20carcinoma%20cell%20line%3aKato%20III.NCig10057.10436-106E4.hg19.GCTATA.bam 10442-106F1 10442-106F1 schwannoma cell line:HS-PSS Homo sapiens GCTATA standard whole cell standard whole cell 10442-106F1.rna 10442-106F1.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.4; A260A280:2.07; A260A230:2 OP-SOLEXA-nanoCAGE-Direct-v1.4 866 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10058 NCig10058 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male schwannoma%20cell%20line%3aHS-PSS.NCig10058.10442-106F1.hg19.GCTATA.bam 10444-106F3 10444-106F3 glioblastoma cell line:A172 Homo sapiens GCTATA standard whole cell standard whole cell 10444-106F3.rna 10444-106F3.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:8.7; A260A280:2.11; A260A230:1.62 OP-SOLEXA-nanoCAGE-Direct-v1.4 866 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10059 NCig10059 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male glioblastoma%20cell%20line%3aA172.NCig10059.10444-106F3.hg19.GCTATA.bam 10454-106G4 10454-106G4 chronic myelogenous leukemia cell line:K562 Homo sapiens GCTATA standard whole cell standard whole cell 10454-106G4.rna 10454-106G4.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:10; A260A280:2.12; A260A230:2.04 OP-SOLEXA-nanoCAGE-Direct-v1.4 866 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10060 NCig10060 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female chronic%20myelogenous%20leukemia%20cell%20line%3aK562.NCig10060.10454-106G4.hg19.GCTATA.bam 10464-106H5 10464-106H5 acute lymphoblastic leukemia (T-ALL) cell line:Jurkat Homo sapiens GCTATA standard whole cell standard whole cell 10464-106H5.rna 10464-106H5.rna total RNA comment:Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:""; rna_sample_type:total RNA; extract_method:standard whole cell; RIN:9.7; A260A280:2.1; A260A230:1.61 OP-SOLEXA-nanoCAGE-Direct-v1.4 866 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10061 NCig10061 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ /sequencedata/Solexa/110608_HWUSI-EAS566_00043_FC70M0TAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male acute%20lymphoblastic%20leukemia%20%28T-ALL%29%20cell%20line%3aJurkat.NCig10061.10464-106H5.hg19.GCTATA.bam 10508-107D4 10508-107D4 neuroblastoma cell line:CHP-134, tech_rep2 Homo sapiens GCTATA NA NA 10508-107D4.rna 10508-107D4.rna Total RNA Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:"" OP-SOLEXA-nanoCAGE-Direct-v1.4 961 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10126 NCig10126 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male neuroblastoma%20cell%20line%3aCHP-134%2c%20tech_rep2.NCig10126.10508-107D4.hg19.GCTATA.bam 10552-107I3 10552-107I3 cervical cancer cell line:D98-AH2, tech_rep2 Homo sapiens GCTATA NA NA 10552-107I3.rna 10552-107I3.rna Total RNA Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:"" OP-SOLEXA-nanoCAGE-Direct-v1.4 962 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10127 NCig10127 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female cervical%20cancer%20cell%20line%3aD98-AH2%2c%20tech_rep2.NCig10127.10552-107I3.hg19.GCTATA.bam 10558-107I9 10558-107I9 osteosarcoma cell line:HS-Os-1, tech_rep2 Homo sapiens GCTATA NA NA 10558-107I9.rna 10558-107I9.rna Total RNA Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:"" OP-SOLEXA-nanoCAGE-Direct-v1.4 963 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10128 NCig10128 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female osteosarcoma%20cell%20line%3aHS-Os-1%2c%20tech_rep2.NCig10128.10558-107I9.hg19.GCTATA.bam 10410-106B5 10410-106B5 extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS, tech_rep2 Homo sapiens GCTATA NA NA 10410-106B5.rna 10410-106B5.rna Total RNA Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:"" OP-SOLEXA-nanoCAGE-Direct-v1.4 964 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10129 NCig10129 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female extraskeletal%20myxoid%20chondrosarcoma%20cell%20line%3aH-EMC-SS%2c%20tech_rep2.NCig10129.10410-106B5.hg19.GCTATA.bam 10441-106E9 10441-106E9 synovial sarcoma cell line:HS-SY-II, tech_rep2 Homo sapiens GCTATA NA NA 10441-106E9.rna 10441-106E9.rna Total RNA Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:"" OP-SOLEXA-nanoCAGE-Direct-v1.4 965 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10130 NCig10130 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 male synovial%20sarcoma%20cell%20line%3aHS-SY-II%2c%20tech_rep2.NCig10130.10441-106E9.hg19.GCTATA.bam 10474-106I6 10474-106I6 myeloma cell line:PCM6, tech-rep2 Homo sapiens GCTATA NA NA 10474-106I6.rna 10474-106I6.rna Total RNA Sample category:"FANTOM5 cell line"; company:"RIKEN Bioresource centre"; RNA lot number:""; RNA Catalog number:"" OP-SOLEXA-nanoCAGE-Direct-v1.4 966 OP-SOLEXA-nanoCAGE-Direct-v1.4 NCig10131 NCig10131 OP-Illumina-sequencing-PairedEnd-v3.0 OP-Illumina-sequencing-PairedEnd-v3.0 NA NA NA /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ /sequencedata/Solexa/110520_HWUSI-EAS747_00040_FC64GRTAAXX/ OP-WORKFLOW-CAGEscan-FANTOM5-v1.0 female myeloma%20cell%20line%3aPCM6%2c%20tech-rep2.NCig10131.10474-106I6.hg19.GCTATA.bam